Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia

NCT02931565 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped The study was prematurely terminated due to enrollment challenges.

Conditions

Achalasia

Interventions

DRUG: Olinciguat
DRUG: Matching Placebo

Sponsor

Cyclerion Therapeutics